Search - tctmd.com

Displaying 741 - 760 of 8267

Sort: Relevancy | Date

News Daily News

Temperature Highs and Lows Leave Their Mark on CV Deaths

L.A. McKeown

June 03, 2024

News Daily News

Pollution Deserves More Attention in Cardiology—and More Action

Yael L. Maxwell

June 03, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Daily News

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

Todd Neale

May 31, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Daily News

Patient Decision Aid Improves Shared Decision-making in Aortic Stenosis

Yael L. Maxwell

May 28, 2024

News Conference News HRS 2024

LEADR: Small Diameter ICD Lead Meets Efficacy and Safety Thresholds

L.A. McKeown

May 27, 2024

News Conference News EuroPCR 2024

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

Caitlin E. Cox

May 24, 2024

News Conference News HRS 2024

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

Michael O'Riordan

May 23, 2024

News Conference News HRS 2024

Aveir DR Dual-Chamber Leadless Pacemaker Looks Solid at 1 Year

Todd Neale

May 23, 2024

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

L.A. McKeown

May 23, 2024

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

News Conference News ESOC 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

Todd Neale

May 16, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Presentation EuroPCR 2024

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

Presenter: Mateusz Tajstra

May 15, 2024

Advertisement

Temperature Highs and Lows Leave Their Mark on CV Deaths

Pollution Deserves More Attention in Cardiology—and More Action

June 2024 Dispatch for the CV Team

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

Patient Decision Aid Improves Shared Decision-making in Aortic Stenosis

LEADR: Small Diameter ICD Lead Meets Efficacy and Safety Thresholds

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

Aveir DR Dual-Chamber Leadless Pacemaker Looks Solid at 1 Year

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content